Retatrutide Triple Agonist | GIP • GLP-1 • Glucagon Retatrutide is a next-generation peptide designed to target GIP, GLP-1, and glucagon receptors, enabling simultaneous multi-pathway metabolic signaling. Engineered for advanced research applications, it provides a broader and more integrated signaling profile than traditional single- or dual-agonist compounds—supporting investigation into energy balance, glucose regulation, and weight-related mechanisms. ________________________________________ Specifications • Form: Lyophilized powder Freeze-dried powder form for stable storage and easy reconstitution. • Quantity: 10 mg per vial • 99% Purity – HPLC Tested ________________________________________ Handling & Storage Store in a cool, dry place away from light. Refrigeration required after reconstitution store between 5-8 degrees ________________________________________ Quality Standard Lab Tested and Manufactured under controlled conditions and supplied as research-grade material. ________________________________________ Shipping Express shipping available within Australia.
